Pharmaceuticals

Global Precision Oncology Market Projected to Expand at 10.6% CAGR by 2029

November 20, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Was The Precision Oncology Market Worth In 2025, And What Is Its Anticipated Value By 2029?

The precision oncology market has seen rapid expansion in recent years. It is forecast to increase from $95.73 billion in 2024 to $106.21 billion in 2025, achieving a compound annual growth rate (CAGR) of 11.0%. This market’s historical growth can be attributed to an increasing number of companion diagnostics receiving approval, a heightened focus on biomarker discovery and validation, rising investments in oncology research and innovation, an expansion in precision oncology clinical trials, and a growing preference for minimally invasive diagnostic techniques.

The precision oncology market is poised for significant expansion over the coming years. Its valuation is projected to reach $158.90 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 10.6%. This anticipated growth during the forecast period stems from factors such as the increasing incidence of cancer, the growing acceptance of genomics-based diagnostic tools, heightened awareness among both patients and medical professionals, the expanded use of next-generation sequencing, and the escalating need for targeted cancer treatments. Key trends anticipated for the forecast period encompass advancements in liquid biopsy technologies, the sophisticated application of single-cell sequencing for tumor examination, the creation of decentralized testing platforms, pioneering work in radiogenomics for treatment strategy, and progress in developing patient-specific cancer vaccines.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27395&type=smp

What Are The Top Growth Drivers Impacting The Precision Oncology Market Outlook?

Growing recognition and a move towards personalized treatments are anticipated to fuel the expansion of the precision oncology market in the future. These therapies are tailored medical interventions, crafted based on a person’s unique genetic profile, biological markers, and particular disease features, with the aim of boosting efficacy and minimizing adverse reactions. The rise of personalized therapies is attributed to progress in genomic technologies, which facilitate the accurate detection of mutations that drive diseases, leading to more potent and focused therapeutic approaches. Precision oncology contributes to the advancement of personalized therapies by employing genomic and molecular profiling to customize cancer treatments according to the unique genetic composition of a patient’s tumor. As an illustration, in February 2023, GOV.UK, a government department based in the UK, reported that the Health and Social Care Secretary had signed a Memorandum of Understanding with BioNTech SE. This agreement aims to further cancer vaccine research in England, with a target of providing 10,000 personalized therapy doses to UK patients by 2030. Consequently, the growing recognition and adoption of personalized therapies are propelling the expansion of the precision oncology market.

What Are The Major Segment Types Covered In The Precision Oncology Market?

The precision oncology market covered in this report is segmented

1) By Type: Genomic Sequencing, Immunotherapy

2) By Product Type: Genetic Tests, Biomarker-Based Tests, Therapeutics

3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Skin Cancer, Stomach Cancer, Other Cancers

4) By Technology: Next-Generation Sequencing, Bioinformatics, Molecular Imaging, Liquid Biopsy

5) By End-users: Hospitals, Research Laboratories, Pharmaceutical Companies, Diagnostic Centers

Subsegments:

1) By Genomic Sequencing: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Gene Sequencing

2) By Immunotherapy: Immune Checkpoint Inhibitors, Cancer Vaccines, Adoptive Cell Therapy

What Trends Are Redefining The Precision Oncology Market Dynamics?

Leading companies operating in the precision oncology market are concentrating on developing novel approaches, such as the molecular tumor board, to support individualized treatment decisions by integrating genomic information with clinical context. A molecular tumor board is a dedicated panel of specialists that analyzes and interprets complex genomic and molecular test data to guide precision-driven cancer therapies tailored to the specific tumor characteristics of individual patients. For instance, in December 2024, Aster DM Healthcare Ltd., a UAE-based healthcare provider, launched a precision oncology clinic as part of three personalized cancer care initiatives designed to transform treatment through data-driven, genomic-focused strategies. This clinic delivers customized cancer therapy based on each patient’s tumor genetic profile, enabling more precise, effective treatments with reduced side effects. This approach enhances treatment outcomes, minimizes toxicity, and improves quality of life by aligning therapies to the unique molecular features of a patient’s cancer.

Which Leading Companies Dominate The Precision Oncology Market Share?

Major companies operating in the precision oncology market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc., Novartis AG, Eli Lilly and Company, Amgen Inc., Agilent Technologies Inc., Illumina Inc., Sysmex Corporation, Qiagen N.V., Exact Sciences Corporation, NeoGenomics Laboratories Inc., Myriad Genetics Inc., Invitae Corporation, Caris Life Sciences, Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Strata Oncology Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/precision-oncology-global-market-report

Which Regional Markets Are Contributing Most To The Precision Oncology Industry Expansion?

North America was the largest region in the precision oncology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision oncology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Precision Oncology Market Report:

https://www.thebusinessresearchcompany.com/customise?id=27395&type=smp

Browse Through More Reports Similar to the Global Precision Oncology Market 2025, By The Business Research Company

Precast Concrete Market 2025

https://www.thebusinessresearchcompany.com/report/precast-concrete-market

Boiler Tank And Shipping Container Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/boiler-tank-and-shipping-container-global-market-report

Drill Pipe Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drill-pipe-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795